Q2 Trading Statement

London & Quadrant Housing Trust
07 November 2025
 

London & Quadrant Housing Trust Trading Update for the period ending 30 September 2025

 

 

London & Quadrant Housing Trust ('L&Q') is today issuing its consolidated unaudited trading update for the six months ended 30 September 2025 ('2025 Q2'). All statement of comprehensive income comparatives are to L&Q's consolidated unaudited prior year equivalent period being the six months ended 30 September 2024 ('2024 Q2').

 

HIGHLIGHTS

 

·    There are 110,214 homes owned or managed (as at 31 March 2025: 109,659)

·    L&Q has completed 1,052 new residential homes (2024 Q2: 950)

·    Turnover was £511m (2024 Q2: £540m)

·    EBITDA-MRI1 was £199m (2024 Q2: £201m)

·    EBITDA-MRI margin2 was 36% (2024 Q2: 36%)

·    EBITDA-MRI margin (excluding sales)3 was 47% (2024 Q2: 45%)

·    Gross sales EBITDA-MRI margin4 was 10% (2024 Q2: 13%)

·    Net sales EBITDA-MRI margin5 was (3)% (2024 Q2: 4%)

·    EBITDA-MRI interest cover6 was 182% (2024 Q2: 164%)

·    EBITDA-MRI social housing lettings interest cover7 was 170% (2024 Q2: 145%)

·    Operating surplus was £199m (2024 Q2: £217m)

·    Debt to assets8 was 41% (2024 Q2: 40%)

·    Sales as a % of turnover10 was 22% (2024 Q2: 22%)

 

Commenting on the results Edward Farnsworth, Executive Group Director Finance said:

"L&Q's unaudited Q2 results reflect continued delivery against our corporate strategy, with a strong focus on investing in existing homes and services. Through our £3bn, 15-year Major Works Investment Programme, we've improved more than 15,300 homes since 2023. We're also making excellent progress on the sector's largest building safety programme, with inspections completed at over 2,000 buildings.

 

In August, the Regulator of Social Housing reaffirmed our compliance with the governance, financial viability and new consumer standards. In awarding our V2 rating for financial viability, the Regulator recognised that like other large housebuilders in the sector, we balance a number of material risks within our financial plan related to our development and sales programme, and our increased investment in existing homes, but that these risks are managed through effective reporting and oversight.

 

We continue to take steps to simplify and strengthen our organisation. In the quarter, we progressed plans to sell our private rented sector business and entered into contract for the transfer of 3,500 homes in South Buckinghamshire-subject to resident consultation and approvals. These changes support our strategy to focus on areas with the greatest concentration of homes, enabling better value and service for residents.

 

We continue to engage with government and partners to shape the implementation of June's Comprehensive Spending Review and look forward to further detail in the upcoming Budget. We continue to seek opportunities to deliver new affordable and social housing where it does not divert from our strategic aim to derisk our business and prioritise investment in existing homes.  This quarter saw key milestones including the completion of 645 affordable homes at Kidbrooke Village, topping-out of the third phase at Beam Park, and planning approval for our New Street scheme in Trafford, which will deliver much-needed affordable homes in Altrincham town centre."

 

FORWARD GUIDANCE FOR THE YEAR ENDING 31 MARCH 2026

 

We project operating surplus between £340m - £360m and EBITDA in the range of £270m to £290m. We forecast gross capital expenditure11 to be c.£314m as our development pipeline slows. We expect to deliver c. 2,069 new residential homes of which c. 73% is expected to be for social housing tenures.

 

Financial Metrics

Forward Guidance to 31 March 2026

EBITDA MRI margin2

26% - 28%

EBITDA MRI margin (excluding sales)3

30% - 35%

Gross sales EBITDA MRI margin4

c3%

EBITDA MRI interest cover6

145% - 155%

EBITDA MRI Social housing lettings interest Cover7

155% - 165%

Debt to assets8

<33%

Gross debt to EBITDA MRI9

<15x

Sales as a % of turnover10

< 23%

 

HOUSING COMPLETIONS

L&Q, including joint ventures, has completed 1,052 (2024 Q2: 950) residential homes in the financial year to date. This comprises of 792 (2024 Q2: 746) completions for social housing tenures (75%) and 204 (2024 Q2: 204) completions for market tenures (25%). During that same time, 636 new build residential homes commenced on site (2024 Q2: 472) with the majority of starts being later phases of existing developments.

DEVELOPMENT PIPELINE

L&Q, including joint ventures, is operating from 85 (2024 Q2: 100) active sites. L&Q has approved 5 (2024 Q2: 554) homes during the financial year bringing total homes in the approved development pipeline to 8,074 (2024 Q2: 10,250), of which 69% are currently on site. Of the homes approved in the development pipeline 47% are for social housing tenures and 53% are for market tenures. L&Q holds a further potential 25,480 (2024 Q2: 25,480) strategic land plots.

The future projected cost of the entire development pipeline (including work in progress and developments not yet committed or on site) that extends until the financial year ending 31 March 2040 is estimated at £1.8bn (2024 Q2: £2.4bn) of which £1.2bn (67%) is currently committed (2024 Q2: £1.9bn).

UNAUDITED FINANCIALS

The unaudited financials exclude further adjustments that are subject to audit review.

 

Statement of Comprehensive Income

 

2025 Q2  

(£m)

2024 Q2

 (£m)

Change

Turnover

 

 

 

Non-sales

445

445


Sales

66

95


 

511

540

(5%)

Operating costs and cost of sales

 

 

 

Non-sales

(309)

(290)


Sales

(67)

(90)


 

(376)

(380)

 1% 

Surplus on disposal of fixed assets and investments

66

57


Share of profits from joint ventures

(2)

(1)


Change in value of investment property

-

-


Operating surplus

199

217

(8%)

Net interest charge

 (106)

(116)


Other finance income/ (costs)

-

(3)


Disposal of business interest

-

(119)


Taxation

-

-


93

(21)

542%

 

EBITDA MRI and Net Cash Interest Paid

 

2025 Q2 

(£m)

2024 Q2

 (£m)

Change

Operating surplus

199

217


Change in value of investment property

-

-


Amortised government grant

(15)

(13)


Depreciation

54

52


Impairment

-

-


Capitalised major repairs

(39)

(55)


EBITDA MRI

199

201

(1%) 





Net interest charge

(105)

(114)


Capitalised interest

(5)

(8)


(110)

(122)

(11%) 

 

Statement of Financial Position

 

2025 Q2 

(£m)

31 March 2025 (£m)

Change (£m)

Housing properties

11,864

11,807

57

Other fixed assets

96

93

3

Investments

1,543

1,573

(30)

Net current assets / (liabilities)

(221)

118

(339)

Total assets less current liabilities

13,282

13,591

(309)

 

Loans due > one year

 

5,051

 

5,415

 

(364)

Unamortised grant liabilities

1,980

1,996

(16)

Other long-term liabilities

404

426

(22)

Capital and reserves

5,847

5,754

93

Total non-current liabilities and reserves

13,282

13,591

 (309)

 

Non-Sales Activities

 

2025 Q2 

(£m)

2024 Q2

 (£m)

Change (£m)

Net rents receivable

422

414

8

Charges for support services

2

5

(3)

Amortised government grants

15

13

2

Other income

6

13

(7)

Turnover

445

445

-

Management costs

(47)

(41)

(6)

Service costs

(62)

(64)

2

Maintenance costs

(130)

(113)

(17)

Support costs

(4)

(5)

1

Depreciation & impairment

(54)

(52)

(3)

Other costs

(12)

(15)

4

Operating costs

(309)

(290)

(19)

Surplus on disposal of fixed assets

66

                57

9

Change in value of investment property

-

-

-

Operating surplus

201

              212

(11)

 

Arrears

 

Current tenant arrears for all tenures are at 5.70% (as at 31 March 2025: 5.20%)

 

Sales Activities

 

The cost of sales is inclusive of capitalised interest and overhead costs:

 

2025 Q2 

(£m)

2024 Q2

 (£m)

Change (£m)

Property sales income

66

87

(21)

Land sales income

-

9

(9)

Turnover from sales (excluding JV's)

66

96

(30)

Cost of property sales

(60)

(79)

19

Cost of land sales

-

(2)

2

Operating costs

(6)

(9)

3

Impairment

-

-

-

Total costs (excluding JV's)

(66)

(90)

24

Operating Surplus (excluding JV's)

-

6

(6)

Joint venture turnover

57

27

30

Joint venture cost of sales

(51)

(26)

(25)

Joint venture operating costs

(8)

(2)

(6)

Impairment of investment in JV's

-

-

-

Share of (losses)/profits from joint ventures

(2)

(1)

(2)

 

AVERAGE SELLING PRICE

 

The average selling price, including JVs, for outright market sales during the financial year to date was £361k (2024 Q2: £372k). The average selling price of first tranche shared ownership sales during the financial year to date was £403k (2024 Q2: £409k) with an average first tranche sale of 31% (2024 Q2: 32%).

 

SALES MARGINS

 

The cost of sales is inclusive of capitalised interest and overhead costs but excludes impairment:

 

 

Shared

Owner-

ship

Outright

Sales (Non-JV)

Land Sales

Outright Sales (JV's)

2025 Q2

 2024 Q2

Change


(£m)

(£m)

(£m)

(£m)

(£m)

(£m)


Turnover

45

21

-

57

123

123

-

Cost of sales

(41)

(19)

-

(51)

(111)

(107)

(4)

Gross profit

4

2

-

6

12

16

(4)

Gross EBITDA margin

8%

9%

-

11%

10%

13%

(3%)

Operating costs

(5)

(2)

-

(8)

(15)

(11)

(4)

Operating (loss)/ surplus

(1)

-

-

(2)

(3)

5

(8)

Net EBITDA margin

(2%)

(1%)

-

(4%)

(3%)

4%

(7%)

  

 

UNSOLD STOCK

 

As at 30 September 2025, L&Q, including joint ventures, held 694 completed homes (2024 Q2: 652) as unsold stock with a projected revenue of £101m (2024 Q2: £95m). Projected revenue for shared ownership assumes a first tranche sale of 25%.

 

Of the total unsold stock, 0% has been held as stock for less than one month and 81% is for shared ownership, a tenure where we would expect to continue to show a higher comparative level of unsold stock due to bulk handovers in short time periods and limitations to pre-sale meaning gradual sales rates. In the year to date, L&Q has handed over 282 and sold 372 shared-ownership homes.

 

L&Q's forward order book excluding joint ventures consists of 63 exchanged homes with projected revenue of £23m and 207 reservations with projected revenue of £41m.

 

Tenure

Projected Revenue (£m)

No. of Homes

<1 Month

1-3 Months

3-6 Months

6-12 Months

>12 Months

Shared Ownership

66

559

1

154

26

150

228

Outright Sale (non-JV's)

7

15

-

-

2

7

6

Total excluding JV's

73

574

1

154

28

157

234

Outright Sale (JCA's)

-

5

-

-

-

3

2

Outright Sale (JCE's)

28

115

2

65

16

26

6

Total Joint Ventures

28

120

2

65

16

29

8

Total Unsold Stock

101

694

3

219

44

186

242

 

NET DEBT AND LIQUIDITY

 

As at 30 September 2025, net debt (excluding derivative financial liabilities) was £5,408m (as at 31 March 2025: £5,428m) and available liquidity within the group in the form of committed un-drawn revolving credit facilities and non-restricted cash was at £1,068m (as at 31 March 2025: £1,051m). Approximately 54% of L&Q's loan facilities and 64% of drawn loan facilities are at a fixed cost. L&Q has £940m of debt maturities within the next 12 months.

 

UNENCUMBERED ASSETS

 

 

2025 Q2

 

31 March 2025

No. of homes owned or managed

110,214

109,659

No. of social housing homes provided as collateral against debt facilities

(50,724)

(54,566)

No. of private rented homes provided as collateral against debt facilities

(1,295)

(1,295)

Total no. of unencumbered homes owned or under management

58,195

53,798

% of homes under management held as collateral against debt facilities

47%

51%

Unencumbered asset ratio12

47%

46%

 

L&Q CREDIT RATINGS

 

As at date of trading statement release:

 

Rating Agency

S&P

Moody's

Fitch

Long-term credit ratings

BBB+/Stable

A3/Stable

A-/Stable

 

 

Notes:

1 Operating surplus - change in value of investment properties - amortised government grant + depreciation + impairment - capitalised major repairs +/- actuarial losses/gains in pension schemes

2 EBITDA MRI / (turnover + turnover from joint ventures - amortised government grant)

3 EBITDA MRI from non-sales activities / turnover from non-sales activities

4 Gross profit from sales + impairment / turnover from sales including joint ventures

5 Operating surplus from sales + impairment / turnover from sales including joint ventures

6 EBITDA MRI / net cash interest paid

7 EBITDA MRI from social housing lettings / net cash interest paid

8 Net debt (excluding derivative financial liabilities) / total assets less current liabilities

9 Gross debt / EBITDA MRI

10 Sales turnover (including joint ventures) / (turnover plus turnover from joint ventures)

11 Capitalised development expenditure + acquisition of investment property + purchase of other fixed assets

12 100% less (loans due after more than 1 year + derivative liabilities + unamortised grant liability) / total assets less current liabilities

 

This trading update contains certain forward-looking statements about the future outlook for L&Q. Although the Directors believe that these statements are based upon reasonable assumptions, any such statements should be treated with caution as the future outlook may be influenced by factors that could cause actual outcomes and results to be materially different.

 

For further information, please contact:

investors@lqgroup.org.uk

 

James Howell, Director of Partnerships                     020 8189 1596

 

www.lqgroup.org.uk

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings